• Home
  • About
  • Services
    • Research & Development
    • Manufacturing
      • Liquid Dose Manufacturing
      • Solid Dose Manufacturing
    • Packaging
    • Quality Assurance
  • Facilities
  • News
    • CPhI Frankfurt
  • Contact
  • FAQs
Avema Pharma Solutions
Menu
  • Home
  • About
  • Services
    • Research & Development
    • Manufacturing
      • Liquid Dose Manufacturing
      • Solid Dose Manufacturing
    • Packaging
    • Quality Assurance
  • Facilities
  • News
    • CPhI Frankfurt
  • Contact
  • FAQs
CPhI North America
Uncategorized

Avéma Pharma Solutions to attend CPhI North America

August 2, 2021 / 1058 /0 comments

Join Avéma Pharma Solutions at CPhI North America (August 10-12, Philadelphia Convention Center) at booth #1325. Attending the show on behalf of the company will be Jeff Speicher, General Commercial Manager; Dana Toops, President of Avema and Chief Science Officer for PL Developments; Tom Cotter, Executive Vice President of Business Development; Aaron Dely, Senior Director of Global Research; and Chris Shores, PMP Portfolio Manager.

Our team will be on hand to discuss how Avéma can help you bring your products to market quickly, efficiently and cost-effectively, from concept through commercialization, including support for FDA submissions.

About CPhI

CPhI organizes the most important and widespread series of global pharmaceutical events. With massive events throughout Asia, South America, Europe, and beyond…more than 500,000 powerful and respected pharma players from every aspect of the supply chain understand that CPhI is where they connect to learn, grow, and conduct business. With a 30-year tradition and an infrastructure fine-tuned to unite buyers, sellers, and industry trailblazers, we expanded this iconic worldwide events portfolio into the most progressive mega market on earth. Enter CPhI North America. The U.S. alone accounts for 40% of the world’s pharmaceutical sales and is home to 6 of the top 11 companies. But much more than that, this is a place of community-building connections. A forum for thought leadership. The hub of innovation. And it all comes to life at CPhI North America.

Share Post
Previous
Avéma Pharma Solutions Announces Plans to Expand Miami R&D and Manufacturing Capabilities
Next
Join Avéma Pharma Solutions at CPhI North America 2022

About Author

Avema

Other posts by Avema

Related posts

Avema is a full service CDMO
Uncategorized
Read more

Join Avéma Pharma Solutions at CPhI North America 2022

April 28, 2022 / 612 /0 comments

Avéma Pharma Solutions is pleased to be attending CPhI in Philadelphia (May 17-19, Philadelphia Convention Center) at Booth #1315. We look forward to seeing our…

Continue reading
blue gloves with pills copy
Uncategorized
Read more

Avéma Pharma Solutions Announces Plans to Expand Miami R&D and Manufacturing Capabilities

August 2, 2021 / 1049 /0 comments

As Pharma and biotech companies increasingly turn to contract development and manufacturing organizations (CDMOs) as extensions of their development and manufacturing departments, Avéma Pharma Solutions…

Continue reading
Lessons Learned
Uncategorized
Read more

Free Webinar! Lessons Learned: Choosing & Managing a CDMO

May 17, 2021 / 1203 /0 comments

Avéma Pharma Solutions, a division of PL Developments (PLD), is in the unique position being both a consumer and supplier of global CDMO services for…

Continue reading

PLD Purchases Teva’s OTC Portfolio

September 19, 2019 / 2882 /0 comments

On June 28, 2019 PL Developments, the parent company of Avema Contract Services, bought the U.S. store-brand, over-the-counter medicine division of Teva, which is headquartered…

Continue reading

Avéma Contract Services to Exhibit at CPhI North America 2019

April 19, 2019 / 2511 /0 comments

Westbury, NY – April 19, 2019 – Avéma Contract Services, a Contract Development Manufacturing Organization (CDMO) powered by PL Developments, will showcase its range of…

Continue reading

Leave a reply Cancel reply

Search

HomeAbout UsServicesFacilitiesContact UsFaqs
© 2022. All Rights Reserved
Contact: 1.516.693.7384